Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

30.4K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
30.4K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Diabetic Retinopathy01:27

Diabetic Retinopathy

55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Diabetic Nephropathy01:28

Diabetic Nephropathy

32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

886
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

19
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polish Society of Gynecologists and Obstetricians guidelines on intrapartum fetal monitoring.

Ginekologia polska·2026
Same author

Genetic variants of progesterone receptor in etiology of preterm delivery.

Ginekologia polska·2022
Same author

The role of corticoliberin concentration levels and placental CRH receptors 1 and 2 in the prolongation of pregnancy.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2022
Same author

Fetal growth trajectory in type 1 pregestational diabetes (PGDM) - an ultrasound study.

Ginekologia polska·2021
Same author

Outcome dependent twin growth curves based on birth weight percentiles for Polish population.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2020
Same author

Cortisol metabolism in pregnancies with small for gestational age neonates.

Scientific reports·2019

Related Experiment Video

Updated: May 4, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.4K

Endothelial dysfunction in the pathogenesis of pre-eclampsia.

Agata Szpera-Gozdziewicz1, Grzegorz H Breborowicz1

  • 1Department of Perinatology and Gynecology, Poznan University of Medical Sciences, Polna 33 St., 60-535, Poznan, Poland.

Frontiers in Bioscience (Landmark Edition)
|January 7, 2014
PubMed
Summary

Pre-eclampsia pathogenesis involves placental issues and maternal factors, leading to an imbalance of angiogenic proteins. This imbalance, characterized by increased anti-angiogenic factors like sFlt1 and sEng, contributes to endothelial dysfunction in pregnancy.

More Related Videos

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

17.7K
Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

1.0K

Related Experiment Videos

Last Updated: May 4, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.4K
Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

17.7K
Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

1.0K

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Vascular Biology

Background:

  • Pre-eclampsia is a complex pregnancy disorder with multifactorial causes.
  • Pathophysiology likely involves fetal/placental and maternal factors, including abnormal placental development and endothelial dysfunction.
  • An imbalance between pro-angiogenic and anti-angiogenic factors is implicated.

Purpose of the Study:

  • To explore the multifactorial pathogenesis of pre-eclampsia.
  • To investigate the roles of angiogenic and anti-angiogenic factors in pre-eclampsia.
  • To understand the contribution of endothelial cells and microparticles to pre-eclampsia.

Main Methods:

  • Review of existing theories and evidence on pre-eclampsia pathogenesis.
  • Analysis of the roles of specific proteins: soluble Fms-like tyrosine kinase 1 (sFlt1), soluble endoglin (sEng), placental growth factor (PlGF), and vascular endothelial growth factor (VEGF).
  • Consideration of the potential involvement of circulating endothelial cells (CECs), endothelial progenitor cells (EPCs), and microparticles.

Main Results:

  • Placental overproduction of anti-angiogenic proteins (sFlt1, sEng) in pre-eclampsia.
  • Reduced circulating levels of pro-angiogenic peptides (PlGF, VEGF) in pre-eclampsia patients.
  • Imbalances in CECs, EPCs, and microparticles are associated with endothelial insufficiency, though their exact role in pre-eclampsia pathogenesis is unclear.

Conclusions:

  • Pre-eclampsia pathogenesis is multifactorial, involving placental dysfunction and maternal factors.
  • An imbalance favoring anti-angiogenic factors (sFlt1, sEng) over pro-angiogenic factors (PlGF, VEGF) is a key feature.
  • Further research is needed to elucidate the precise roles of endothelial cells and microparticles in pre-eclampsia.